Q BioMed Inc. announced the appointment of Dr. Amy Ripka and Dr. Rick Panicucci, to its board of scientific advisors. Dr. Amy Ripka is the Executive Director of Medicinal Chemistry at WuXi AppTec. She started her career at Bristol Myers Squibb and over 17 years, has worked in various capacities in medicinal chemistry with many small companies, including EnVivo (FORUM) Pharmaceuticals as Head of Chemistry, Infinity, Daiamed, HydraBiosciences and FoldRx. Her current responsibilities include strategic planning in medicinal chemistry, early library drug design utilizing multiple in-silico methods, hit optimization and overall screening architectures, to advance early stage compounds through Phase I-II clinical development. Dr. Ripka's therapeutic specialties include Neuroscience, Oncology, Thrombosis and Anti-Infective Disease areas. Dr. Rick Panicucci is the Vice President of Pharmaceutical Development at WuXi AppTec. He is responsible for providing scientific leadership in the areas of Developability, Formulation Development and GMP Manufacturing.